Efficacy of the exhalation delivery system with fluticasone in patients who remain symptomatic on standard nasal steroid sprays

Volume: 11, Issue: 5, Pages: 837 - 845
Published: Sep 24, 2020
Abstract
Standard nasal steroid sprays are often first-line treatment for chronic rhinosinusitis (CRS), but many patients remain symptomatic despite their use. The exhalation delivery system with fluticasone (EDS-FLU) has been shown to be efficacious in mixed populations of symptomatic patients, but the question remains whether benefits would be similar in those already on traditional steroid sprays. The goal of this study was to compare EDS-FLU...
Paper Details
Title
Efficacy of the exhalation delivery system with fluticasone in patients who remain symptomatic on standard nasal steroid sprays
Published Date
Sep 24, 2020
Volume
11
Issue
5
Pages
837 - 845
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.